Citation 41339

ROSSKOPF,F: KRAUS,J: FRANZ,G:. (1992). IMMUNOLOGICAL AND ANTITUMOR EFFECTS OF COUMARIN AND SOME DERIVATIVES.. 47(2)

Citation Details

Title	IMMUNOLOGICAL AND ANTITUMOR EFFECTS OF COUMARIN AND SOME DERIVATIVES.
Authors	ROSSKOPF,F: KRAUS,J: FRANZ,G:
Year	1992
Volume	47
Issue	2

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (6)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIC ACID,PARA:	INACTIVE
2	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,PARA:	INACTIVE
3	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,PARA:	WEAK ACTIVITY
4	MACROPHAGE CYTOTOXICITY ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIC ACID,PARA:	INACTIVE
5	PHAGOCYTOSIS RATE INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,PARA:	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIC ACID,META:	INACTIVE
2	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,META:	WEAK ACTIVITY
3	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,META:	WEAK ACTIVITY
4	MACROPHAGE CYTOTOXICITY ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIC ACID,META:	INACTIVE
5	PHAGOCYTOSIS RATE INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,META:	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIC ACID,ORTHO:	INACTIVE
2	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,ORTHO:	WEAK ACTIVITY
3	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,ORTHO:	WEAK ACTIVITY
4	MACROPHAGE CYTOTOXICITY ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIC ACID,ORTHO:	INACTIVE
5	PHAGOCYTOSIS RATE INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,ORTHO:	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	INACTIVE
2	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
3	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
4	MACROPHAGE CYTOTOXICITY ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	INACTIVE
5	PHAGOCYTOSIS RATE DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	ACTIVE
6	PHAGOCYTOSIS RATE INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN,4-HYDROXY:	INACTIVE
2	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN,4-HYDROXY:	WEAK ACTIVITY
3	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN,4-HYDROXY:	WEAK ACTIVITY
4	MACROPHAGE CYTOTOXICITY ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN,4-HYDROXY:	INACTIVE
5	PHAGOCYTOSIS RATE INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN,4-HYDROXY:	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	INACTIVE
2	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	WEAK ACTIVITY
3	LYMPHOCYTE BLASTOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	WEAK ACTIVITY
4	MACROPHAGE CYTOTOXICITY ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	INACTIVE
5	PHAGOCYTOSIS RATE INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	WEAK ACTIVITY

Show SPARQL Queries (1)